Evidence map›Paper›PMID 34010331›Full record

ArticlePloS one2021

Profiles and outcomes in patients with COVID-19 admitted to wards of a French oncohematological hospital: A clustering approach.

Louise Bondeelle, Sylvie Chevret, Stéphane Cassonnet, Stéphanie Harel, Blandine Denis, Nathalie de Castro, Anne Bergeron, Saint Louis CORE Team Group

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Clinical-epidemiologic variation in patients treated in the first and second wave of COVID-19 in Lambayeque, Peru: A cluster analysis.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Louise BondeelleUniversité de Paris, Hôpital Saint-Louis, AP-HP, Service de Pneumologie, Paris, France.
Sylvie ChevretECSTRRA Team, Université de Paris, Inserm, Paris, France.
Stéphane CassonnetService de Biostatistique et Information Médicale, Hôpital Saint-Louis, AP-HP, Paris, France.
Stéphanie HarelHôpital Saint-Louis, AP-HP, Service d'Immuno-hématologie, Paris, France.
Blandine DenisHôpital Saint-Louis, AP-HP, Service de Maladies Infectieuses, Paris, France.
Nathalie de CastroHôpital Saint-Louis, AP-HP, Service de Maladies Infectieuses, Paris, France.
Anne BergeronUniversité de Paris, Hôpital Saint-Louis, AP-HP, Service de Pneumologie, Paris, France.ORCID 0000-0003-2156-254X
Saint Louis CORE Team Group
Assistance Publique – Hôpitaux de Paris · FRInserm · FRUniversité Paris Cité · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesAlthough some prognostic factors for COVID-19 were consistently identified across the studies, differences were found for other factors that could be due to the characteristics of the study populations and the variables incorporated into the statistical model. We aimed to a priori identify specific patient profiles and then assess their association with the outcomes in COVID-19 patients with respiratory symptoms admitted specifically to hospital wards.

methodsWe conducted a retrospective single-center study from February 2020 to April 2020. A non-supervised cluster analysis was first used to detect patient profiles based on characteristics at admission of 220 consecutive patients admitted to our institution. Then, we assessed the prognostic value using Cox regression analyses to predict survival.

resultsThree clusters were identified, with 47 patients in cluster 1, 87 in cluster 2, and 86 in cluster 3; the presentation of the patients differed among the clusters. Cluster 1 mostly included sexagenarian patients with active malignancies who were admitted early after the onset of COVID-19. Cluster 2 included the oldest patients, who were generally overweight and had hypertension and renal insufficiency, while cluster 3 included the youngest patients, who had gastrointestinal symptoms and delayed admission. Sixty-day survival rates were 74.3%, 50.6% and 96.5% in clusters 1, 2, and 3, respectively. This was confirmed by the multivariable Cox analyses that showed the prognostic value of these patterns.

conclusionThe cluster approach seems appropriate and pragmatic for the early identification of patient profiles that could help physicians segregate patients according to their prognosis.

Indexed as

AgedClinical Decision RulesCluster AnalysisCOVID-19FemaleFranceHospitalizationHospitalsHumansMaleMiddle AgedPrognosisRetrospective StudiesSARS-CoV-2

Identifiers

PMID34010331
PMCPMC8133400
OpenAlexW3161342273

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.